ICMR Releases Application Form For Testing Of Vector Control Products

Mumbai: In a significant development aimed at enhancing public health initiatives, the Indian Council of Medical Research (ICMR) has unveiled an application form for the testing of vector control products. This move comes as part of the ongoing efforts to combat vector-borne diseases effectively.

Vector-borne diseases pose a significant threat to public health worldwide, with India being no exception. To address this challenge, ICMR has been actively involved in evaluating the efficacy and safety of vector control products. The newly released application form is expected to streamline the process for manufacturers and applicants seeking approval for their products.

The application form outlines the evaluation criteria and requirements for testing vector control products. It emphasizes the importance of integrated vector management as a cost-effective and sustainable strategy for disease prevention. Chemical control methods, including indoor residual spraying, larvicides, space spray products, and insecticide-treated nets, are highlighted as key components of vector control efforts.

Central to the application process is the need for data on human and environmental safety, efficacy, and quality of vector control products. Manufacturers and applicants are required to submit comprehensive documentation to support their applications, including data from laboratory and multi-center field trials.

Furthermore, the application form aligns with the “Common Protocol for Uniform Evaluation of Public Health Pesticides for use in Vector Control, Third Edition (2023),” ensuring consistency and standardization in the evaluation process. The form also allows for flexibility, with the possibility of additional information or documents being requested by ICMR as deemed necessary.

The release of the application form underscores ICMR’s commitment to ensuring the effectiveness and safety of vector control products used in disease control efforts. By establishing clear guidelines and requirements, the form aims to expedite the evaluation process while maintaining rigorous standards.

As vector-borne diseases continue to pose a significant public health challenge, the importance of robust testing and evaluation mechanisms cannot be overstated. With the introduction of the application form, ICMR takes a proactive step towards strengthening vector control efforts and safeguarding public health across India.

For manufacturers and applicants seeking to submit their products for evaluation, the application form provides a structured framework to navigate the process effectively. By adhering to the guidelines outlined in the form, stakeholders can contribute to the ongoing efforts to combat vector-borne diseases and protect communities from their adverse effects.

The release of the application form marks a significant milestone in India’s public health landscape, demonstrating ICMR’s commitment to advancing vector control strategies and promoting the well-being of its citizens.

Related Posts

Fujifilm India launches therapeutic endoscopy portfolio at Endocon 2026

Fujifilm India, a leading healthcare technology company, has expanded its ELUXEO 8000 endoscopy portfolio with the launch of its next-generation therapeutic gastroscopes at Endocon 2026. India is witnessing a growing…

Draft bill proposes powers for DIs to inspect online pharmacy office premises

Amidst years of uncertainty over the regulation of e-pharmacies in the country, the draft Drugs, Medical Devices and Cosmetics Bill, 2026, proposes to bestow the powers with the drugs inspectors…

Leave a Reply

Your email address will not be published. Required fields are marked *

You Missed

Fujifilm India launches therapeutic endoscopy portfolio at Endocon 2026

Fujifilm India launches therapeutic endoscopy portfolio at Endocon 2026

Draft bill proposes powers for DIs to inspect online pharmacy office premises

Draft bill proposes powers for DIs to inspect online pharmacy office premises

Argentina committed to reducing barriers to facilitate entry of Indian pharma sector: Government

Argentina committed to reducing barriers to facilitate entry of Indian pharma sector: Government

FDA cancels drug sale licences of Cipla Pharma & Life Sciences’ Pune Carry and Forwarding unit

FDA cancels drug sale licences of Cipla Pharma & Life Sciences’ Pune Carry and Forwarding unit

Delhi DCA mandates digital tracking for controlled substances on new DMS portal

Delhi DCA mandates digital tracking for controlled substances on new DMS portal

How much of Healthcare Research reaches Bedside in India? Or gets Lost in Translation?

How much of Healthcare Research reaches Bedside in India? Or gets Lost in Translation?